Coherus Biosciences Inc (NASDAQ:CHRS) traded at $1.12 at close of the session on Tuesday, February 18 and made a downward move of -5.08% on its previous day’s price. Coherus Biosciences Inc has a market cap of $129.80 million and is expected to release its quarterly
Coherus Biosciences Inc (NASDAQ:CHRS) shares, rose in value on Wednesday, February 12, with the stock price up by 0.90% to the previous day’s close as strong demand from buyers drove the stock to $1.12. Actively observing the price movement in the last trading, the stock
Coherus Biosciences Inc (NASDAQ:CHRS) price closed higher on Tuesday, February 04, and jumping 4.50% above its previous close. A look at the daily price movement shows that the last close reads $1.11, with intraday deals fluctuated between $1.11 and $1.23. The company’s 5Y monthly beta
Coherus Biosciences Inc (NASDAQ:CHRS) traded at $1.24 at close of the session on Tuesday, January 24 and made a downward move of -3.12% on its previous day’s price. Looking at the stock we see that its previous close was $1.28 and the beta (5Y monthly)
The trading price of Coherus Biosciences Inc (NASDAQ:CHRS) closed lower on Tuesday, January 21, and closing at $1.32, -5.04% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.315 and $1.4278. In examining the
Coherus Biosciences Inc (NASDAQ:CHRS) price on current trading day, fall -4.79% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.39. A look at the stock’s price movement, the level at last check in today’s session was $1.46,
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
